Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
30%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
HRTS
42
HOLDINGS
26%
ALSO IN THNR
THNR
18
HOLDINGS
65%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.8% | 14.4% | 11.8% |
|
MERCK & CO. INC. | 4.3% | 5.1% | 4.3% |
 |
ASTRAZENECA PLC | 4.0% | 4.7% | 4.0% |
|
ABBVIE INC | 2.5% | 5.0% | 2.5% |
|
AMGEN INC | 2.0% | 6.3% | 2.0% |
HRTS Overweight Relative to THNR
|
UNITEDHEALTH GROUP INC | 5.5% |
 |
NOVO NORDISK A/S-B | 5.0% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.4% |
|
THERMO FISHER SCIENTIFIC INC | 3.8% |
|
JOHNSON & JOHNSON | 3.7% |
|
NOVARTIS AG | 3.3% |
|
GILEAD SCIENCES INC | 3.3% |
|
REVOLUTION MEDICINES, INC. | 3.2% |
|
VERTEX PHARMACEUTICALS INC | 2.9% |
|
ABBOTT LABORATORIES | 2.8% |
HRTS Underweight Relative to THNR
|
NOVO-NORDISK A/S-SPONS ADR | -14.1% |
|
PFIZER INC | -4.8% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -4.8% |
 |
INNOVENT BIOLOGICS, INC. | -4.7% |
|
AMGEN INC | -4.3% |
 |
CHINA PHARMACEUTICAL GROUP | -4.0% |
 |
SHIONOGI & CO LTD | -4.0% |
|
CHUGAI PHARMACEUTICAL CO LTD | -4.0% |
|
REGENERON PHARMACEUTICALS | -3.9% |
|
ELI LILLY & CO | -2.6% |